Exosomes: Breakthrough or Buzzword? In this episode of The Recharge Biomedical Podcast, Dr. Edward Park sits down with immunologist and exosome pioneer Dr. Duncan Ross to unpack the accidental discovery that launched a new wave of regenerative research.
Together, they explore exosome therapy's true potential—and serious pitfalls—from shady industry practices to FDA oversight. Learn what separates high-quality products from the rest and why ethical, evidence-based standards are more critical than ever.
Curious about the next frontier in regenerative medicine? This episode is your deep dive into the science and ethics of exosomes.
----
What if a stem cell serum accidentally sparked regeneration and changed the future of healing? In this episode, I’m joined by Dr. Duncan Ross as we dive into the fascinating science of exosomes. Together, we unpack their accidental discovery and the challenges of poor quality control in the field. Drawing on Dr. Ross’s expertise in immunology and product development, we explore the critical importance of rigorous testing, FDA oversight, and why focusing on RNA and protein levels—rather than just particle counts—should become the new standard for assessing exosome potency. The future of healing is closer than we think.
----
Dr. Duncan Ross is an immunologist and founder in the exosome space, known for pioneering sterile, RNA-rich exosome products with consistent quality control standards. He’s spent over a decade refining production methods and advocating for ethical, evidence-based practices in regenerative medicine.
----
Linkedin: https://www.linkedin.com/in/dredpark/
Instagram: https://www.instagram.com/dredpark/?hl=en
Website: www.rechargebiomedical.com
Recharge Biomedical | Substack
----
PODCAST
Thank you for listening.
Please subscribe and share.
This podcast is produced by DrTalks.com https://drtalks.com/podcast-service/
